Literature DB >> 3397766

Cerebral herniation in patients receiving cisplatin.

R W Walker1, J G Cairncross, J B Posner.   

Abstract

5 Patients with intracranial mass lesions are described who experienced cerebral herniation and coma following intravenous cisplatin therapy. Although the pathogenesis of the acute cerebral swelling is unknown, it is most likely multifactorial. Possible contributing factors include pre-existing cerebral edema, acute hypo-osmolality with fluid shifts into an already swollen brain, seizures and possible direct neurotoxicity of cisplatin.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3397766     DOI: 10.1007/bf00163542

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  19 in total

1.  Hyponatremia and renal wasting of sodium in patients with malfunction of the central nervous system.

Authors:  M GOLDBERG; J S HANDLER
Journal:  N Engl J Med       Date:  1960-11-24       Impact factor: 91.245

2.  Peripheral neuropathy as a complication of cis-dichlorodiammineplatinum(II) treatment: a case report.

Authors:  A Kedar; M E Cohen; A I Freeman
Journal:  Cancer Treat Rep       Date:  1978-05

3.  Cerebrospinal fluid-platinum kinetics of cisplatin in man.

Authors:  J P Armand; J P Macquet; A F LeRoy
Journal:  Cancer Treat Rep       Date:  1983-11

4.  Release of antidiuretic hormone during mass-induced elevation of intracranial pressure.

Authors:  L Gaufin; W R Skowsky; S J Goodman
Journal:  J Neurosurg       Date:  1977-05       Impact factor: 5.115

5.  Phase II study of cisplatin in recurrent astrocytomas in adults: a Southwest Oncology Group Study.

Authors:  D J Stewart; R M O'Bryan; M Al-Sarraf; J J Costanzi; N Oishi
Journal:  J Neurooncol       Date:  1983       Impact factor: 4.130

6.  Cisplatin neuropathy. Clinical, electrophysiologic, morphologic, and toxicologic studies.

Authors:  S W Thompson; L E Davis; M Kornfeld; R D Hilgers; J C Standefer
Journal:  Cancer       Date:  1984-10-01       Impact factor: 6.860

7.  Systemic chemotherapy for a primary germ cell tumor of the brain: a pharmacokinetic study.

Authors:  S Ginsberg; J Kirshner; S Reich; L Panasci; T Finkelstein; S Fandrich; A Fitzpatrick; L Shechtman; R Comis
Journal:  Cancer Treat Rep       Date:  1981 May-Jun

8.  Phase II trail cisplatin in refractory childhood cancer: Children's Cancer Study Group Report.

Authors:  E S Baum; P Gaynon; L Greenberg; W Krivit; D Hammond
Journal:  Cancer Treat Rep       Date:  1981 Sep-Oct

9.  Intracranial pressure during epileptic seizures.

Authors:  A J Gabor; A G Brooks; R P Scobey; G H Parsons
Journal:  Electroencephalogr Clin Neurophysiol       Date:  1984-06

10.  Cisplatin therapy in recurrent childhood brain tumors.

Authors:  A B Khan; B J D'Souza; M D Wharam; L A Champion; L F Sinks; S Y Woo; D C McCullough; B G Leventhal
Journal:  Cancer Treat Rep       Date:  1982-12
View more
  2 in total

1.  Phase II study of weekly dose-intensified cisplatin chemotherapy with oral etoposide in recurrent glioma.

Authors:  M J van den Bent; L Pronk; P A Sillevis Smitt; C J Vecht; F A Eskens; J Verweij
Journal:  J Neurooncol       Date:  1999-08       Impact factor: 4.130

2.  Early chemotherapy and concurrent radio-chemotherapy in high grade glioma.

Authors:  A A Brandes; A Rigon; P Zampieri; E Scelzi; P Amistà; F Berti; A Rotilio; M Gardiman; M V Fiorentino
Journal:  J Neurooncol       Date:  1996-12       Impact factor: 4.130

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.